RT Book, Section A1 Usatine, Richard P. A1 Sabella, Camille A1 Smith, Mindy Ann A1 Mayeaux, E.J. A1 Chumley, Heidi S. A1 Appachi, Elumalai SR Print(0) ID 1114877802 T1 Pigmentary Conditions T2 The Color Atlas of Pediatrics YR 2015 FD 2015 PB McGraw-Hill Education PP New York, NY SN 978-0-07-176701-9 LK accesspediatrics.mhmedical.com/content.aspx?aid=1114877802 RD 2024/03/28 AB References1Taïeb A Picardo M; VETF Members: The definition and assessment of vitiligo: a consensus report of the Vitiligo European Task Force. Pigment Cell Res. 2007;20(1):27–35.17250545[PubMed: ]2Njoo MD Westerhof W. Vitiligo: pathogenesis and treatment. Am J Clin Dermatol. 2001;2(3):167–181.3KrügerC SchallreuterKU. A review of the worldwide prevalence of vitiligo in children/adolescents and adults. Int J Dermatol. 2012 Mar 27. doi: 10.1111/j.1365-4632. 2011.05377.x. [Epub ahead of print].4Karaca N Ozturk G Gerceker BT et al. TLR2 and TLR4 gene polymorphisms in Turkish vitiligo patients. J Eur Acad Dermatol Venereol. 2012 Mar 16. doi: 10.1111/j.1468-3083. 2012.04514.x. [Epub ahead of print].5Alghamdi KM Kumar A Taïeb A Ezzedine K. Assessment methods for the evaluation of vitiligo. J Eur Acad Dermatol Venereol. 2012 Mar 15. doi: 10.1111/j.1468-3083. 2012.04505.x. [Epub ahead of print].6Schallreuter KU Lemke R Brandt O et al. Vitiligo and other diseases: coexistence or true association? Hamburg study on 321 patients. Dermatology. 1994;188(4):269–275.8193398[PubMed: ]7Hegedüs L Heidenheim M Gervil M et al. High frequency of thyroid dysfunction in patients with vitiligo. Acta Derm Venereol. 1994;74(2):120–123.7911617[PubMed: ]8Rogosic´ V Bojic´ L Puizina-Ivic´ N et al. Vitiligo and glaucoma – an association or a coincidence? A pilot study. Acta Dermatovenerol Croat. 2010;18(1):21–26.20361884[PubMed: ]9Barona MI Arrunátegui A Falabella R Alzate A. An epidemiologic case-control study in a population with vitiligo. J Am Acad Dermatol. 1995;33(4):621–625.7673496[PubMed: ]10Hacker SM. Common disorders of pigmentation: When are more than cosmetic cover-ups required? Postgrad Med. 1996;99(6):177–186.8668630[PubMed: ]11Bacigalupi RM Postolova A Davis RS. Evidence-based, non-surgical treatments for vitiligo: a review. Am J Clin Dermatol. 2012 Mar 16. doi: 10.2165/11630540-000000000-00000. [Epub ahead of print].12Hossani-Madani AR, Halder RM. Topical treatment and combination approaches for vitiligo: new insights, new developments. G Ital Dermatol Venereol. 2010;145(1):57–78.20197746[PubMed: ]13Kwinter J Pelletier J Khambalia A Pope E. High-potency steroid use in children with vitiligo: a retrospective study. J Am Acad Dermatol. 2007;56(2):236–241.17224367[PubMed: ]14Forschner T Buchholtz S Stockfleth E. Current state of vitiligo therapy—evidence-based analysis of the literature. J Dtsch Dermatol Ges. 2007;5(6):467–475.17537039[PubMed: ]15Alghamdi KM Khurrum H Taieb A Ezzedine K. Treatment of generalized vitiligo with anti-TNF-α agents. J Drugs Dermatol. 2012;11(4):534–539.22453596[PubMed: ]16Whitton ME Pinart M Batchelor J et al. Interventions for vitiligo. Cochrane Database Syst Rev. 2010;(1):CD003263.17Hofer A Hassan AS Legat FJ et al. Optimal weekly frequency of 308-nm excimer laser treatment in vitiligo patients. Br J Dermatol. 2005;152(5):981–985.15888156[PubMed: ]18Viles J Monte D Gawkrodger DJ. Vitiligo. BMJ. 2010;341:c3780.19Horev A Weintraub AY Sergienko R et al. Pregnancy outcome in women with vitiligo. Int J Dermatol. 2011;50(9):1083–1085.22126869[PubMed: ]